Prevalence of antibodies to hepatitis C virus in blood donors and risk groups in Istanbul, Turkey
β Scribed by O. S. Yenen; S. Badur
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 266 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiton Corporation in California. This antigen has been used to develop an ELISA test (Ortho Diagnostic Systems for serum anti-HCV antibodies. Preliminary data have shown that this virus is the major cause of NAN
## Abstract Of 103,203 donations collected in Scotland and Northern Ireland over a 3βmonth period and screened for HCV antibody by Ortho or Abbott secondβgeneration ELISAs, 340 were found repeatedly reactive. Supplementary testing with RIBAβ2 resulted in 77 being classified as positive, 130 as inde